IGF1 and cancer: To examine the effect of short-term disruption of IGF-1 signalling on increased energy balance-related changes in lipid storage and AT function, we employed a pharmacological approach using the IGF-1 R-specific antibody cixutumumab, which has been used in humans to treat a range of malignancies [7,8].